Literature DB >> 11073835

Genetic modifiers of atherosclerosis in mice.

J W Knowles1, N Maeda.   

Abstract

Atherosclerosis is a complex, multifactorial disease with both genetic and environmental determinants. Experimental investigation of the effects of these determinants on the development and progression of atherosclerosis has been greatly facilitated by the use of targeted mouse models of the disease, particularly those resulting from the absence of functional genes for apolipoprotein E or the low density lipoprotein receptor (LDLR). This review focuses on the influence on atherosclerosis of combining apoE or LDLR deficiencies with factors affecting atherogenesis, including (1) inflammatory processes, (2) glucose metabolism, (3) blood pressure, and (4) coagulation and fibrinolysis. We also discuss the general problem of using the mouse to test the effects on atherogenesis of human polymorphic variations and future ways of enhancing the usefulness of these mouse models.

Entities:  

Mesh:

Year:  2000        PMID: 11073835      PMCID: PMC4321895          DOI: 10.1161/01.atv.20.11.2336

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  112 in total

Review 1.  Diabetes and cardiovascular disease.

Authors:  J R Sowers; M A Lester
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

Authors:  E Araki; M A Lipes; M E Patti; J C Brüning; B Haag; R S Johnson; C R Kahn
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

4.  Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis.

Authors:  Q Xiao; M J Danton; D P Witte; M C Kowala; M T Valentine; T H Bugge; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency.

Authors:  Y Matsushima; S Hayashi; M Tachibana
Journal:  Mamm Genome       Date:  1999-04       Impact factor: 2.957

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse.

Authors:  H M Dansky; S A Charlton; M M Harper; J D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

9.  Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice.

Authors:  B Paigen; D Mitchell; K Reue; A Morrow; A J Lusis; R C LeBoeuf
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit.

Authors:  A V Chobanian; A H Lichtenstein; V Nilakhe; C C Haudenschild; R Drago; C Nickerson
Journal:  Hypertension       Date:  1989-08       Impact factor: 10.190

View more
  36 in total

1.  Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds.

Authors:  Nobuyo Maeda; Lance Johnson; Shinja Kim; John Hagaman; Morton Friedman; Robert Reddick
Journal:  Atherosclerosis       Date:  2007-02-01       Impact factor: 5.162

Review 2.  Nuclear receptors and inflammatory diseases.

Authors:  Kun Wang; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2008-03-28

3.  Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.

Authors:  Monica Goldklang; Polina Golovatch; Tina Zelonina; Jordis Trischler; Daniel Rabinowitz; Vincent Lemaître; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-23       Impact factor: 5.464

4.  Improved endothelial dysfunction by Cynanchum wilfordii in apolipoprotein E(-/-) mice fed a high fat/cholesterol diet.

Authors:  Deok Ho Choi; Yun Jung Lee; Hyun Cheol Oh; Ying Lan Cui; Jin Sook Kim; Dae Gill Kang; Ho Sub Lee
Journal:  J Med Food       Date:  2011-11-14       Impact factor: 2.786

Review 5.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 6.  Genetically modified pigs to model human diseases.

Authors:  Tatiana Flisikowska; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2014-02       Impact factor: 3.240

7.  Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.

Authors:  Hyung J Chun; Ziad A Ali; Yoko Kojima; Ramendra K Kundu; Ahmad Y Sheikh; Rani Agrawal; Lixin Zheng; Nicholas J Leeper; Nathan E Pearl; Andrew J Patterson; Joshua P Anderson; Philip S Tsao; Michael J Lenardo; Euan A Ashley; Thomas Quertermous
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

8.  Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides.

Authors:  Xuemei Jia; Stephen Iwanowycz; Junfeng Wang; Fatma Saaoud; Fang Yu; Yuzhen Wang; Jun Hu; Saurabh Chatterjee; Qian Wang; Daping Fan
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-16

9.  A practical approach to using mice in atherosclerosis research.

Authors:  Stewart C Whitman
Journal:  Clin Biochem Rev       Date:  2004-02

10.  Novel cerebrovascular pathology in mice fed a high cholesterol diet.

Authors:  Sonia Franciosi; Miguel A Gama Sosa; Daniel F English; Elizabeth Oler; Twethida Oung; William Gm Janssen; Rita De Gasperi; James Schmeidler; Dara L Dickstein; Christoph Schmitz; Sam Gandy; Patrick R Hof; Joseph D Buxbaum; Gregory A Elder
Journal:  Mol Neurodegener       Date:  2009-10-24       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.